South Korea has issued new mental health AI safety guidelines addressing the risks of emotional dependence on AI chatbots and the dangers of AI-based self-diagnosis, becoming one of the more proactive national regulators to specifically target the psychological risks of AI companionship and mental health tools rather than data privacy or accuracy alone.
What the Guidelines Address
The guidelines specifically call out emotional dependence — the phenomenon where users, particularly those who are isolated or vulnerable, develop reliance on AI chatbots for emotional support in ways that may substitute for rather than supplement human connection or professional care. They also address AI-based self-diagnosis, where users rely on chatbot responses to assess their own mental health symptoms without professional verification, a practice mental health professionals have warned can lead to both over- and under-estimation of genuine clinical risk.
Why This Matters Globally
South Korea’s move comes as governments worldwide grapple with how to regulate AI companion products, with U.S. senators this year pressing AI companies on chatbot companions specifically targeting lonely seniors, and growing clinical evidence — including a Dartmouth-developed chatbot called Therabot showing genuine benefit for anxiety, depression and eating disorders in a published clinical trial — suggesting these tools aren’t uniformly harmful, but require careful design and oversight to avoid risk.
The Evidence Base Is Genuinely Mixed
Research this year has shown both promise and peril: a fine-tuned generative AI chatbot was linked to lower depression, anxiety and eating-disorder risk symptoms in one September study, while separate reporting has documented a rapidly growing number of teens and young adults turning to general-purpose AI chatbots — not clinically validated tools like Therabot — for mental health support and emotional advice, often without any professional oversight or crisis-intervention safeguards built in.
Utah’s Parallel Approach
South Korea’s guidelines echo a different regulatory experiment underway in the U.S. state of Utah, which is building a verification mechanism for its healthcare AI sandbox — a structure that lets AI mental health tools operate under state oversight while data is gathered on real-world safety and efficacy. The two approaches, a national guideline framework in South Korea and a state-level sandbox model in Utah, represent different regulatory philosophies for the same underlying problem.
Clinical Community Reaction
Physicians and mental health professionals have increasingly called for risk-based review processes and clear stop rules for clinical AI agents — mechanisms that would require an AI mental health tool to escalate to human intervention under defined conditions, such as expressions of self-harm risk, rather than continuing an AI-only conversation indefinitely. South Korea’s guidelines reportedly incorporate similar escalation principles, though the specific technical requirements have not been fully detailed in public reporting.
What’s Next
South Korean regulators have not specified enforcement mechanisms or penalties for AI mental health products that fail to comply with the new guidelines, nor a timeline for when compliance will be formally assessed. International policy researchers will likely treat South Korea’s approach as an early test case for whether guideline-based regulation can meaningfully curb emotional-dependence risks without stifling the genuine clinical benefits some AI mental health tools have already demonstrated.
Photo: JESHOOTS-com / PIXABAY via Pixabay
